AI-generated analysis. Always verify with the original filing.
Candel Therapeutics, Inc. announced its financial results for the quarter and year ended December 31, 2025 on March 12, 2026. The announcement is furnished under Item 2.02 with Exhibit 99.1 press release attached.
Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On March 12, 2026, Candel Therapeutics, Inc. announced its financial results for the quarter and year ended Decem
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated March 12, 2026 104 Cover Page Interactive Data File (embedde